We talk with Dr. Yazan Migdady about chronic Graft Versus Host Disease, post transplant cytopenias, and what patients and caregivers should understand about recovery after a blood or marrow transplant. Chronic GVHD develops when the donated immune system begins reacting against the patient's own cells. Dr. Migdady explains that it occurs in roughly half of transplant patients, although severe cases are much less common. When GVHD affects the bone marrow, it can interfere with the body's ability to produce healthy red blood cells, white blood cells, and platelets.
Low blood counts after transplant can have several causes. GVHD itself may interfere with blood production or cause the immune system to attack blood cells. Medications used to control GVHD can also lower blood counts. Infections, poor graft function, and other transplant related complications can contribute as well. This is why regular monitoring and a thorough evaluation are so important.
Dr. Migdady also explains when transfusions may be needed. Decisions are based not only on laboratory numbers but also on symptoms, bleeding risk, medications, and the patient's overall condition. Transfusions provide temporary support while the body is unable to produce enough blood cells on its own.
Treatment options continue to improve. In recent years, several therapies for chronic GVHD have become available, giving clinicians more ways to individualize care. Clinical trials remain an important part of that progress and can sometimes give patients access to promising treatments years before they become widely available. Researchers are also investigating more targeted approaches for immune mediated cytopenias. The goal is to target the specific immune cells or pathways responsible rather than broadly suppressing the immune system.
We also address the common idea that chronic GVHD eventually "burns out." For many patients, symptoms do improve as the immune system gradually settles down, and some can eventually stop treatment. However, this process varies considerably. GVHD can last months or years and can flare again, so patients need continued monitoring.
Finally, we focus on the emotional side of recovery. Isolation is intended to protect patients while their immune systems are vulnerable, but staying connected with family and friends remains important. Caregivers should prepare for a marathon rather than a sprint, build their own support network, and take care of their own physical and emotional needs.
Dr. Migdady closes by sharing several memorable patient stories that remind us that advances in transplantation are ultimately about the people behind the science.
Thank you to our Season 21 Sponsors:
Incyte: https://incyte.com/
Sanofi: https://www.sanofi.com/
(00:00) Intro
(01:52) What Is Chronic Graft Versus Host Disease?
(03:53) Can a Little GvHD Be Beneficial?
(05:25) Why Blood Counts Can Stay Low After Transplant
(07:50) Finding the Right GvHD Treatment
(08:43) Why Clinical Trials Matter
(09:58) When Are Blood Transfusions Needed?
(11:58) New Therapies for Post Transplant Cytopenias
(14:20) Does Chronic GvHD Eventually Burn Out?
(15:56) Coping With Isolation During GvHD
(17:36) Advice for Caregivers
(19:43) Patient Stories That Made a Lasting Impact
(22:36) Closing Thoughts
National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.
nbmtLINK Website: https://www.nbmtlink.org/
Check out our valued nbmtLINK resource books, some for sale, some free as downloadable, https://www.nbmtlink.org/shop/
nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINK
Follow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/
The nbmtLINK YouTube Page can be found by clicking here.
This content is provided for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. It is crucial to consult directly with a qualified healthcare professional regarding any medical conditions, treatment options, or other health concerns.
The views and opinions expressed by the speakers are their own and do not necessarily reflect the official policy or position of the nbmtLINK. Unless otherwise stated in an official policy, the nbmtLINK does not endorse any specific treatments, products, or services mentioned by the speakers. Reliance on any information provided is solely at your own risk.
The Marrow Masters Podcast is produced by JAG Podcast Productions: https://jagpodcastproductions.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
